Table 2.
Outcome of the study population, in terms of RR, PFS and OS
| 1 Treatment line (N = 50) | >1 Treatment line (N = 63) | Total (N = 113) | p value | ||
|---|---|---|---|---|---|
| RR | PR | 21 (42.0%) | 10 (15.9%) | 31 (27.4%) | 0.0160 |
| SD | 13 (26.0%) | 26 (41.3%) | 39 (34.5%) | ||
| PD | 16 (32.0%) | 27 (42.9%) | 43 (38.1%) | ||
| PFS (months) | Median (95% CI) | 9.0 (5.6, 15.4) | 5.5 (4.1, 6.8) | 6.3 (5.3, 8.1) | 0.0200 |
| Two years PFS | % (95% CI) | 22.0 (13.0, 37.1) | 12.7 (6.6, 37.1) | 16.8 (11.2, 25.3) | |
| OS (months) | Median (95% CI) | 13.2 (9.8, 32.1) | 10.8 (6.5, 14.5) | 12.0 (8.1, 14.6) | 0.0200 |
| Two years OS | % (95% CI) | 41.6 (29.9, 57.9) | 22.9 (14.5, 36.2) | 31.1 (23.6, 41.1) |